Quinn Yao

Quinn (Kun) Yao is a seasoned professional in the biotechnology and pharmaceutical fields, holding the position of Senior Director and Head of MSAT at AstraZeneca's Rockville Manufacturing Center since June 2024. Previously, Quinn served as Vice President and Head of CMC and Tech Ops at NeuExcell Therapeutics, overseeing the advancement of CNS gene therapy candidates. With a strong track record, Quinn has held significant roles such as Executive Director at Passage Bio, Analytical & Technology Development Leader at Spark Therapeutics, and various leadership positions within AstraZeneca and MedImmune, focusing on analytical development, process characterization, and CMC strategy. Quinn possesses extensive expertise in analytical and technology development and has contributed to the fields of gene therapy and vaccine development throughout a robust career, beginning with a Ph.D. in Molecular Virology & Immunology from the University of Maryland.